Publication details

Sorafenib and sunitinib in metastatic renal cell carcinoma: Cost-effectiveness analysis in reimbursement proceedings vs. data from clinical practice

Authors

ONDRÁČKOVÁ Barbora DEMLOVÁ Regina

Year of publication 2010
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info